Millions of people take upwards of five medications a day, but testing the side effects of such combinations is impractical. Now, Stanford computer scientists have figured out how to predict side effects using artificial intelligence.
Last month alone, 23 percent of Americans took two or more prescription drugs, according to one CDC estimate. Furthermore, 39 percent over age 65 take five or more, a number that’s increased three-fold in the last several decades. And if that isn’t surprising enough, try this one: in many cases, doctors have no idea what side effects might arise from adding another drug to a patient’s personal pharmacy.
The problem is that with so many drugs currently on the U.S. pharmaceutical market, “it’s practically impossible to test a new drug in combination with all other drugs, because just for one drug that would be five thousand new experiments,” said Marinka Zitnik, a postdoctoral fellow in computer science. With some new drug combinations, she said, “truly we don’t know what will happen.”
But computer science may be able to help. In a paper presented July 10 at the 2018 meeting of the International Society for Computational Biology in Chicago. Zitnik and colleagues Monica Agrawal, a master’s student, and Jure Leskovec, an associate professor of computer science, describe an artificial intelligence system for predicting, not simply tracking, potential side effects from drug combinations. That system, called Decagon, could help doctors make better decisions about which drugs to prescribe and help researchers find better combinations of drugs to treat complex diseases.
Too many combinations
Once it’s available to doctors in a more user-friendly form, Decagon’s predictions would be an improvement over what’s available now, which essentially comes down to chance – a patient takes one drug, starts taking another and then develops a headache or worse. There are about 1,000 known side effects and 5,000 drugs on the market, making for nearly 125 billion possible side effects between all possible pairs of drugs. Most of these have never been prescribed together, let alone systematically studied.
Zitnik, Agrawal and Leskovec realized they could get around that problem by studying how drugs affect the underlying cellular machinery in the body. They composed a massive network describing how the more than 19,000 proteins in our bodies interact with each other and how different drugs affect these proteins. Using more than 4 million known associations between drugs and side effects, the team then designed a method to identify patterns in how side effects arise based on how drugs target different proteins.
To do that, the team turned to deep learning, a kind of artificial intelligence modeled after the brain. In essence, deep learning looks at complex data and extracts from them abstract, sometimes counterintuitive patterns in the data. In this case, the researchers designed their system to infer patterns about drug interaction side effects and predict previously unseen consequences from taking two drugs together.
Predicting complications
Just because Decagon found a pattern doesn’t necessarily make it real, so the group looked to see if its predictions came true In many cases, they did. For example, there was no indication in the team’s data that the combination of atorvastatin, a cholesterol drug, and amlopidine, a blood pressure medication, could lead to muscle inflammation. Yet Decagon predicted that it would, and it was right. Although it did not appear in the original data, a case report from 2017 suggested the drug combination had led to a dangerous kind of muscle inflammation.
That example was born out in other cases as well. When they searched the medical literature for evidence of 10 side effects predicted by Decagon but not in their original data, the team members found that five out of the ten have recently been confirmed, lending further credence to Decagon’s predictions.
“It was surprising that protein interaction networks reveal so much about drug side effects,” said Leskovec, who is a member of Stanford Bio-X, Stanford Neurosciences Institute and the Chan Zuckerberg Biohub.
Right now, Decagon only considers side effects associated with pairs of drugs. In the future, the team members hope to extend their results to include more complex regimens, Leskovec said. They also hope to create a more user-friendly tool to give doctors guidance on whether it’s a good idea to prescribe a particular drug to a particular patient and to help researchers developing drug regimens for complex diseases with fewer side effects.
“Today, drug side effects are discovered essentially by accident,” Leskovec said, “and our approach has the potential to lead to more effective and safer health care.”
The Latest on: Drug side effects
[google_news title=”” keyword=”drug side effects” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug side effects
- Weight-loss drugs are a risky but real solution to a lot of health problems: Johann Harion May 9, 2024 at 11:34 am
The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs' author Johann Hari discusses the side effects of drugs like Ozempic and Wegovy on 'The Big Money Show.' ...
- Ozempic butt: Women report two MORE unflattering and scary side effects of weight-loss drugon May 9, 2024 at 10:50 am
Neither symptom is officially recognized as a side-effect of Ozempic, but doctors say Ozempic butt is to be expected because of the rapid weight loss the drug causes which leaves the skin too little ...
- See The 50 Most Prescribed Drugs In The US Todayon May 8, 2024 at 11:29 am
Millions rely on medication to manage their health. Whether it’s a quick prescription to treat an illness or a long-term medication for a chronic illness, the vast majority of Americans do ...
- Baby Boomers' 14 Least Favorite Drug Brands: Rankedon May 8, 2024 at 10:30 am
Baby boomers are currently one of the oldest demographics. For this reason, they’re also some of the most familiar with medications. But with so many choices, some brands just don’t have much ...
- Ozempic Face — and Now Ozempic Breast and Butt? What's Really Going on with These Side Effects?on May 8, 2024 at 9:26 am
Ozempic and others in its class (marketed under the brand names Wegovy and Mounjaro) work in the brain to impact satiety. While Ozempic is approved by the FDA for people with type 2 diabetes and not ...
- ‘Ozempic Breasts’ Side Effect Reported by People Taking Weight Loss Drugson May 8, 2024 at 8:43 am
People taking GLP-1 weight loss drugs like Ozempic and Wegovy are reporting unexpected changes in the size and shape of their breasts.
- Ozempic babies: A surprise side effect of weight loss drugson May 7, 2024 at 11:00 pm
Women taking Ozempic or similar drugs for diabetes or weight loss are taking to social media to commiserate about an unexpected side effect — "surprise pregnancies," said The Washington Post. There is ...
- Expert's important warning over 'weight loss' drug Ozempic side effects after losing 3ston May 5, 2024 at 3:26 am
A health expert has issued an important warning about the possible side effects of taking Ozempic as a weight loss drug after he used it to help lose three stone ...
- Expert warns of Ozempic side effects after losing three stone on weight-loss drugon May 4, 2024 at 4:01 pm
Ozempic is a drug primarily prescribed to diabetic people, however it is commonly used as an off-label drug for weight loss ...
- Side effects of 'weight loss' drug Ozempic as expert loses three stoneon May 4, 2024 at 12:59 am
Ozempic is a drug primarily prescribed to diabetic people, however it is commonly used as an off-label drug for weight loss ...
via Bing News